U.S. and WHO Relations, Diversity in Medicine, and Weight Loss Medications

In this episode, Dr. Chi-Ming Chow delves into the complex relationship between the U.S. and the World Health Organization, focusing on the implications of the U.S. withdrawal. He examines the impact of funding cuts and the importance of global health cooperation. The episode highlights the communication pause from U.S. federal health agencies and its effects on public health. Dr. Chow explores the benefits of diversity in the medical profession, emphasizing its educational roles. The discussion shifts to weight loss medications like Ozempic and GLP-1 drugs, exploring their health benefits. Lawrence Gostin's perspective on the U.S. withdrawal from WHO is considered, alongside healthcare policy changes enacted by former President Trump.